Selected current data on metronomic therapy (and its promise) from India
- PMID: 27275444
- PMCID: PMC4873693
- DOI: 10.4103/2278-330X.181623
Selected current data on metronomic therapy (and its promise) from India
References
-
- Patil V, Noronha V, Krishna V, Joshi A, Prabhash K. Oral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers. Clin Oncol (R Coll Radiol) 2013;25:388. - PubMed
-
- Patil V, Karpe A, Noronha V, Joshi A, Muddu V, Bhattacharjee A, et al. Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers. Indian J Cancer. 2015;52:629–31. - PubMed
-
- Noronha V, Joshi A, Marfatia S, Patil V, Juvekar S, Arya S, et al. Health-related quality of life in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of the head and neck in India. Support Care Cancer. 2016;24:1595–602. - PubMed
-
- Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Bhosale B, et al. A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck. Oral Oncol. 2015;51:279–86. - PubMed
-
- Pai PS, Vaidya AD, Prabhash K, Banavali SD. Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis. Indian J Cancer. 2013;50:135–41. - PubMed
LinkOut - more resources
Full Text Sources